A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (USA)- DIAPREVENT

Clinical trial NCT00751842 · TERMINATED

Trial details

NCT number: NCT00751842
Sponsor: Diamyd Therapeutics AB
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2008-09-01
Primary completion: 2012-03-01
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.